Piramal Pharma Q1FY25 results: Net loss narrows at Rs 88.64 crore
“We have had a good start to the financial year with a steady all-round performance…,” Piramal Pharma Chairperson Nandini Piramal
Continue readingThe Number One Finance & Business Blog!
“We have had a good start to the financial year with a steady all-round performance…,” Piramal Pharma Chairperson Nandini Piramal
Continue reading